Rosen Law Firm Reminds ESSA Pharma Inc. Investors of March 25, 2025 Deadline

What’s Happening

New York, NY / Accesswire / February 6, 2025 – Rosen Law Firm, a global investor rights law firm, is reminding purchasers of securities of ESSA Pharma Inc. (NASDAQ:EPIX) between December 12, 2023 and October 31, 2024 (the “Class Period”) of the upcoming lead plaintiff deadline on March 25, 2025. If you bought ESSA Pharma Inc. securities during this time, you may be able to seek compensation through a contingency fee arrangement without any out-of-pocket fees.

How it Affects You

As an investor in ESSA Pharma Inc., it is crucial to be aware of the lead plaintiff deadline and your rights to seek compensation. By taking action before the March 25, 2025 deadline, you may be able to recover losses incurred during the Class Period without incurring any upfront costs. This opportunity allows you to protect your investments and hold companies accountable for any alleged securities violations.

How it Affects the World

The reminder from Rosen Law Firm regarding the lead plaintiff deadline for ESSA Pharma Inc. investors highlights the importance of investor protection and holding corporations accountable for their actions. By seeking compensation for securities violations, investors can help promote transparency and integrity in financial markets, ultimately fostering trust and stability in the global economy.

Conclusion

It is essential for ESSA Pharma Inc. investors to be aware of the upcoming deadline and take action if they believe they have been affected by securities violations. By seeking compensation through a contingency fee arrangement, investors can protect their investments and contribute to a more transparent and accountable financial system. Stay informed and prepared to make informed decisions regarding your investments.